The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition
Open accessAbstract
Significance: This report reveals the influence of sialylation on the activation of epidermal growth factor receptor (EGFR) and sensitivity to tyrosine kinase inhibitors (TKIs) against EGFR phosphorylation. By utilizing biochemical approaches, we demonstrated that EGFR sialylation suppresses EGFR phosphorylation by inhibiting EGF binding and EGFR dimerization. In the TKI-resistant lung cancer cell line with L858R/T790M mutations on EGFR, the levels of phosphorylation at Y1068, Y1086, and Y1173 are upregulated, and sialylation can partially suppress the phosphorylation of EGFR at these sites and enhance EGFR sensitivity to TKI. These findings suggest that sialylation has an important role in tumorigenesis and sensitivity to TKIs by modulating EGFR phosphorylation and the associated signaling network and provide insights for therapeutic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a similar vein, both sialylation and fucosylation modulate epidermal growth factor receptor-mediated intracellular signaling (528 -530).”
From Biological roles of glycans (2017) · cites this paper as [530]
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
Hornbeck, P. V., Zhang, B., Murray, B., Kornhauser, J. M., Latham, V., & Skrzypek, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1267 · Cited by 3,411
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118
EGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227
Yun, C.-H., Boggon, T. J., Li, Y., Woo, M. S., Greulich, H., Meyerson, M., & Eck, M. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.017 · Cited by 1,192
Rozakis-Adcock, M., McGlade, J., Mbamalu, G., Pelicci, G., Daly, R., Li, W., Batzer, A., Thomas, S., Brugge, J., Pelicci, P. G., et al. (1992) · Nature · doi:10.1038/360689a0 · Cited by 973
Lau, K. S., Partridge, E. A., Grigorian, A., Silvescu, C. I., Reinhold, V. N., Demetriou, M., & Dennis, J. W. (2007) · Cell · doi:10.1016/j.cell.2007.01.049 · Cited by 914 · cited 1×
“The number of N-glycans and the degree of branching can regulate the cellsurface expression of EGFR in response to N-acetyl-D-glucosamine (GlcNAc) supplementation (18).”
BackgroundEGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain Dimerization
Ferguson, K. M., Berger, M. B., Mendrola, J. M., Cho, H.-S., Leahy, D. J., & Lemmon, M. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00047-9 · Cited by 801
Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H.-J., Walker, F., Frenkel, M. J., Hoyne, P. A., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00940-6 · Cited by 783
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
Mitsudomi, T., & Yatabe, Y. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07448.x · Cited by 559
Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor.
Batzer, A. G., Rotin, D., Ureña, J. M., Skolnik, E. Y., & Schlessinger, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5192 · Cited by 479
Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome
Rillahan, C. D., Antonopoulos, A., Lefort, C. T., Sonon, R., Azadi, P., Ley, K., Dell, A., Haslam, S. M., & Paulson, J. C. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.999 · Cited by 447
Liu, Y.-C., Yen, H.-Y., Chen, C.-Y., Chen, C.-H., Cheng, P.-F., Juan, Y.-H., Chen, C.-H., Khoo, K.-H., Yu, C.-J., Yang, P.-C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107385108 · Cited by 424
Self-citationSelection of Invasive and Metastatic Subpopulations from a Human Lung Adenocarcinoma Cell Line
Chu, Y.-W., Yang, P.-C., Yang, S.-C., Shyu, Y.-C., Hendrix, M. J. C., Wu, R., & Wu, C.-W. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.3.2837 · Cited by 420
Self-citationStructure-Based View of Epidermal Growth Factor Receptor Regulation
Ferguson, K. M. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125829 · Cited by 368
The role of the EGFR signaling in tumor microenvironment
De Luca, A., Carotenuto, A., Rachiglio, A., Gallo, M., Maiello, M. R., Aldinucci, D., Pinto, A., & Normanno, N. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21260 · Cited by 359
Shan, Y., Eastwood, M. P., Zhang, X., Kim, E. T., Arkhipov, A., Dror, R. O., Jumper, J., Kuriyan, J., & Shaw, D. E. (2012) · Cell · doi:10.1016/j.cell.2012.02.063 · Cited by 357
Core Fucosylation Regulates Epidermal Growth Factor Receptor-mediated Intracellular Signaling
Wang, X., Gu, J., Ihara, H., Miyoshi, E., Honke, K., & Taniguchi, N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510893200 · Cited by 323
Regulation of human EGF receptor by lipids
Coskun, Ü., Grzybek, M., Drechsel, D., & Simons, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105666108 · Cited by 316
Dawson, J. P., Berger, M. B., Lin, C.-C., Schlessinger, J., Lemmon, M. A., & Ferguson, K. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7734-7742.2005 · Cited by 297
Soderquist, A. M., & Carpenter, G. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90787-8 · Cited by 229
Ligand-induced ErbB receptor dimerization
Lemmon, M. A. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.10.024 · Cited by 216
Insights into the Aberrant Activity of Mutant EGFR Kinase Domain and Drug Recognition
Gajiwala, K. S., Feng, J., Ferre, R., Ryan, K., Brodsky, O., Weinrich, S., Kath, J. C., & Stewart, A. (2013) · Structure · doi:10.1016/j.str.2012.11.014 · Cited by 204
Emerging Role of α2,6-Sialic Acid as a Negative Regulator of Galectin Binding and Function
Zhuo, Y., & Bellis, S. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.191429 · Cited by 174
Extracellular domains drive homo‐ but not hetero‐dimerization of erbB receptors
Ferguson, K. M., Darling, P. J., Mohan, M. J., Macatee, T. L., & Lemmon, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4632 · Cited by 154
Tsuda, T., Ikeda, Y., & Taniguchi, N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003400200 · Cited by 121
Merlin, J., Stechly, L., de Beauce, S., Monté, D., Leteurtre, E., SEUNINGEN, I. V., Huet, G., & Pigny, P. (2011) · Oncogene · doi:10.1038/onc.2010.631 · Cited by 116
Morandell, S., Stasyk, T., Skvortsov, S., Ascher, S., & Huber, L. A. (2008) · PROTEOMICS · doi:10.1002/pmic.200800204 · Cited by 111
Song, Y., Aglipay, J. A., Bernstein, J. D., Goswami, S., & Stanley, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2719 · Cited by 104
Mechanistic insights into the activation of oncogenic forms of EGF receptor
Wang, Z., Longo, P. A., Tarrant, M. K., Kim, K., Head, S. A., Leahy, D. J., & Cole, P. A. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2168 · Cited by 100
Saito, T., Okada, S., Ohshima, K., Yamada, E., Sato, M., Uehara, Y., Shimizu, H., Pessin, J. E., & Mori, M. (2004) · Endocrinology · doi:10.1210/en.2004-0401 · Cited by 89
Molecular Determinants of Epidermal Growth Factor Binding: A Molecular Dynamics Study
Sanders, J. M., Wampole, M. E., Thakur, M. L., & Wickstrom, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054136 · Cited by 78
Functional Effects of Glycosylation at Asn-579 of the Epidermal Growth Factor Receptor
Whitson, K., Whitson, S. R., Red-Brewer, M., Mccoy, A. J., Vitali, A. A., Walker, F., Johns, T. G., Beth, A. H., & Staros, J. V. (2005) · Biochemistry · doi:10.1021/bi050751j · Cited by 77
Brugger, W., & Thomas, M. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2011.12.014 · Cited by 69
Sharma, S. V., & Settleman, J. E. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.026 · Cited by 68
Odaka, M., Kohda, D., Lax, I., Schlessinger, J., & Inagaki, F. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021718 · Cited by 59
Yokoe, S., Takahashi, M., Asahi, M., Lee, S. H., Li, W., Osumi, D., Miyoshi, E., & Taniguchi, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3023 · Cited by 57
Zimmer, S., Kahl, P., Buhl, T., Steiner, S., Wardelmann, E., Merkelbach‐Bruse, S., Buettner, R., & Heukamp, L. C. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0509-9 · Cited by 54
Kim, Y., Li, Z., Apetri, M. M., Luo, B., Settleman, J. E., & Anderson, K. S. (2012) · Biochemistry · doi:10.1021/bi300476v · Cited by 47
Li, W., Nakagawa, T., Koyama, N., Wang, X., Jin, J., Mizuno-Horikawa, Y., Gu, J., Miyoshi, E., Kato, I., Honke, K., et al. (2006) · Glycobiology · doi:10.1093/glycob/cwl023 · Cited by 46
Wang, F., Wang, S., Wang, Z., Duan, J., An, T., Zhao, J., Bai, H., & Wang, J. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-65 · Cited by 45
Matsushita, T., Ohyabu, N., Fujitani, N., Naruchi, K., Shimizu, H., Hinou, H., & Nishimura, S. (2012) · Biochemistry · doi:10.1021/bi3013142 · Cited by 35
Research works printed but not linked: 1
- 10.1128/mcb.14.8.5192-5201.1994 · doi:10.1128/mcb.14.8.5192-5201.1994 · Paper page
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Mereiter, S., Balmaña, M., Campos, D., Gomes, J., & Reis, C. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.06.006 · Cited by 565
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Shivatare, S. S., Shivatare, V. S., & Wong, C.-H. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c01032 · Cited by 257
Self-citationWu, J., Chen, S., Liu, H., Zhang, Z., Ni, Z., Chen, J., Yang, Z., Nie, Y., & Fan, D. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0935-8 · Cited by 223
Aptamer Therapeutics in Cancer: Current and Future
Morita, Y., Leslie, M., Kameyama, H., Volk, D., & Tanaka, T. (2018) · Cancers · doi:10.3390/cancers10030080 · Cited by 217
Metadata
- Authors
- Yen, H.-Y., Liu, Y.-C., Chen, N.-Y., Tsai, C.-F., Wang, Y.-T., Chen, Y.-J., Hsu, T.-L., Yang, P.-C., & Wong, C.-H.
- Affiliations
- Institute of Biochemical Sciences and
- Genomics Research Center,
- National Yang Ming University (TW)
- National Taiwan University (TW)
- Institute of Chemistry (CN)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-05-13
- Volume
- 112
- Issue
- 22
- Pages
- 6955-6960
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4460513
- OpenAlex
- W1554182554
- Cited by
- 119
- References
- 47
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 8 · 2023: 9 · 2022: 13 · 2021: 14 · 2020: 11 · 2019: 13 · 2018: 14 · 2017: 11 · 2016: 11
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Keywords
- EGFR phosphorylation, tyrosine kinase inhibitor resistance, gefitinib resistance, lung cancer, receptor dimerization, autophosphorylation, neuraminidase, sialyltransferase inhibitors, desialylation, EGF binding
- MeSH terms
- Gefitinib, Enzyme Inhibitors, Humans, Models, Molecular, Neuraminidase, Phosphorylation, Protein Binding, Protein-Tyrosine Kinases, Quinazolines, Dimerization, Mutation, Missense, Cell Line, Tumor, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.